Twist Bioscience (TWST) Short-term Investments (2018 - 2026)

Twist Bioscience (TWST) has reported Short-term Investments for 9 consecutive years, with $49.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Short-term Investments changed 0.04% year-over-year to $49.4 million in Q2 2026; TTM through Jun 2026 was $49.4 million, a 0.04% change from a year earlier, with the FY2025 full-year figure at $49.4 million, down 1.39% from the prior year.
• Short-term Investments was $49.4 million for Q2 2026 at Twist Bioscience, up from $49.0 million in the prior quarter.
• Over five years, Short-term Investments peaked at $166.2 million in Q1 2022 and troughed at $44.9 million in Q4 2023.
• A 5-year average of $70.9 million and a median of $49.8 million in 2023 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments surged 949.37% in 2022 and tumbled 67.17% in 2023, its largest moves.
• Over 5 years, Short-term Investments stood at $122.0 million in 2022, then sank by 63.23% to $44.9 million in 2023, then increased by 10.14% to $49.4 million in 2024, then fell by 0.05% to $49.4 million in 2025, then increased by 0.01% to $49.4 million in 2026.
• The last three Short-term Investments figures came in at $49.4 million (Q2 2026), $49.0 million (Q1 2026), and $49.4 million (Q4 2025), per Business Quant data.